A new inhibitor could be the key to treating peanut allergy
If you're one of the 75 million people on Earth with a peanut allergy, here's some exciting news: Scientists are getting closer to developing a treatment for the allergy that might not involve stabbing yourself with an EpiPen.
In a new study published in the journal Proceedings of the National Academy of Sciences on Monday, researchers managed to find a way to inhibit an allergic reaction to peanuts. The reaction starts when peanuts enter the person's body and their immune system misinterprets the food as a threat, Newsweek explained. It then creates a protein called immunoglobulin E (IgE) in order to attack the food, which prompt reactions from itchiness and hives to a swelling throat and difficulty breathing.
For this study, the scientists tested the blood of 16 participants who have a peanut allergy, observing the way that IgE binds to the peanut proteins. From there, they were able to develop an inhibitor that would bind to the IgE before it could reach the peanut proteins, thus stopping an allergic reaction from occurring.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This new type of inhibitor is different from other allergy treatments in that it targets IgE without interfering with "any other essential immune system molecules or cells," explained Dr. Basar Bilgicer, co-author of the study and associate professor at the University of Notre Dame. This means that a new treatment based on this type of inhibitor won't stop people's immune systems from carrying out other "very important functions that are vital for patients' well-being."
Because many food allergies work like peanut allergy, this could also mean scientists are closer to developing similar treatments for all sorts of allergens, like other nuts, soy, or dairy. Read more about the study at Newsweek.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
Political cartoons for October 25Cartoons Saturday’s political cartoons include hospital bill trauma, Independence Day, and more
-
Roasted squash and apple soup recipeThe Week Recommends Autumnal soup is full of warming and hearty flavours
-
Ukraine: Donald Trump pivots againIn the Spotlight US president apparently warned Volodymyr Zelenskyy to accept Vladimir Putin’s terms or face destruction during fractious face-to-face
-
Proposed Trump-Putin talks in Budapest on holdSpeed Read Trump apparently has no concrete plans to meet with Putin for Ukraine peace talks
-
Bolivia elects centrist over far-right presidential rivalSpeed Read Relative political unknown Rodrigo Paz, a centrist senator, was elected president
-
Madagascar president in hiding, refuses to resignSpeed Read Andry Rajoelina fled the country amid Gen Z protests and unrest
-
Sanae Takaichi: Japan’s Iron Lady set to be the country’s first woman prime ministerIn the Spotlight Takaichi is a member of Japan’s conservative, nationalist Liberal Democratic Party
-
Israel, Hamas agree to first step of Trump peace planSpeed Read Israel’s military pulls back in Gaza amid prisoner exchange
-
Israel intercepts 2nd Gaza aid flotilla in a weekSpeed Read The Israeli military intercepted a flotilla of nine boats with 145 activists aboard along with medical and food aid
-
Japan poised to get first woman prime ministerSpeed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
Israel and Hamas meet on hostages, Trump’s planSpeed Read Hamas accepted the general terms of Trump’s 20-point plan, including the release of all remaining hostages